Proliferative Diabetic Retinopathy (PDR)
Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01270 | Ranibizumab | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01270 | Ranibizumab | Vascular endothelial growth factor A, long form | target |